- RBT-1 is actively enrolling in a Phase 3 pivotal trial to reduce the risk of post operative complications and improve outcomes following cardiothoracic surgery- SOUTHLAKE, Texas, Oct. 3, 2024...

October 19 conference will unite global arbitration experts and explore critical themes shaping the dispute resolution ecosystem NEW YORK, Oct. 3, 2024 /PRNewswire/ -- The International Centre for...

Utah-based private aviation firm SkyShare today announces it has been named to the 2024 Utah 100, MountainWest Capital Network (MWCN)'s annual list of the fastest-growing companies in Utah....

In this free webinar, learn how innovative data mining approaches are transforming drug safety applications, including target safety assessments (TSAs) and weight of evidence (WoE) assessments....

AX-158 mechanism demonstrates broad potential to treat many autoimmune diseases without causing immunosuppression Phase 1 data with AX-158 suggests it was well tolerated, with a profile that...